Now that commercially available GLP-1s are accessible again, compounding pharmacies are no longer allowed to make copies of them
Chronic stress can impact appetite as well, often leading to emotional eating and cravings for high carb foods and sweets
Eating too little can slow metabolism and prolong a plateau
Incretin-based antidiabetic therapies, such as glucagon-like peptide-1 receptor agonists (GLP-1RAs), may offer benefits for individuals at risk of neurodegeneration due to their central effects on appetite and satiety regulation via the hypothalamus (Reich and Holscher, 2022)
But the times that we have been able to get behind company pricing decisions, it really does seem to be [drug companies] trying to strike the balance between maximizing how much money they can make and making everyone really angry. PBMs are not the only obstacle to consumer-friendly pricing, but to really fuck up the industry, Cuban needs the perfect enemy